Study summary · research use only
Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review article (species not specified; no experimental subjects) discusses elamipretide (SS-31), a synthetic mitochondrial-targeted antioxidant, and its reported roles in mitigating mitochondrial dysfunction. The authors describe SS-31 as associated with reduced oxidative stress, reduced inflammatory processes, maintenance of mitochondrial dynamics, and prevention of cellular apoptosis in prior research. The review compares SS-31 to natural antioxidants and traditional mitochondrial-targeted antioxidants, describes proposed mechanisms by which it modulates mitochondrial function, and summarizes reported applications of SS-31 in mitochondrial dysfunction-associated disorders, along with an outlook on its future development and applications.
Abstract
Due to the pivotal role of mitochondria in the generation of adenosine triphosphate (ATP) and the regulation of cellular homeostasis, mitochondrial dysfunction may exert a profound impact on various physiological systems, potentially precipitating a spectrum of distinct diseases. Consequently, research pertaining to mitochondrial therapeutics has assumed increasing significance, warranting heightened scrutiny. In recent years, the field of mitochondrial therapy has witnessed noteworthy advancements, with active exploration into diverse pharmacological agents aimed at ameliorating mitochondrial function. Elamipretide (SS-31), a novel synthetic mitochondrial-targeted antioxidant, has emerged as a promising candidate with extensive therapeutic potential. Its notable attributes encompass the mitigation of oxidative stress, the suppression of inflammatory processes, the maintenance of mitochondrial dynamics, and the prevention of cellular apoptosis. As such, SS-31 may emerge as a viable choice for the treatment of mitochondrial dysfunction-related ailments in the foreseeable future. This article extensively expounds upon the superiority of SS-31 over natural antioxidants and traditional mitochondrial-targeted antioxidants, delves into its mechanisms of modulating mitochondrial function, and comprehensively summarizes its applications in alleviating mitochondrial dysfunction-associated disorders. Furthermore, we offer a comprehensive outlook on the expansive prospects of SS-31's future development and application.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.